Contact Us

  

Vernalis Therapeutics, Inc.
1160 W. Swedesford Road, Suite 100
Berwyn, PA 19312

t: +1 484 913 0700
f: +1 610 651 5976

To contact Vernalis Therapeutics, Inc. please email vti-enquiries@vernalis.com

 

UK Head Office:

Head Office
Vernalis plc 
100 Berkshire Place
Wharfedale Road
Winnersh,
RG41 5RD

t: +44 (0)118 938 0000
f: +44 (0)118 938 0001

To contact Vernalis plc please email corporatec@vernalis.com

 

Also at:

Vernalis (R&D) Ltd
Granta Park Cambridge
CB21 6GB

t: +44 (0)1223 895555
f: +44 (0)1223 895556

 

If you require medical information on any of our products please email medical@vernalis.com

Latest News

FDA Issues a Complete Response Letter on CCP-07 NDA

Vernalis plc announces today that the US Food and Drug Administration (FDA) has issued a Complete Response Letter (CRL) regarding the New Drug Application (NDA) for CCP-07.

Read more ...

Fact Sheet

For more information on Vernalis, click below to download a copy of our fact sheet

 

Factsheet-Nov14

 

 

 

 

Contact Vernalis Therapeutics

T: 1-484-913-0700
F: 1-610-651 5976

Contact information
Maps and directions
Contact form

To report SUSPECTED ADVERSE REACTIONS, contact Vernalis Therapeutics, Inc. at 1-855-705-9546 and drugsafety@propharmagroup.com or FDA at 1-800-FDA-1088 or www.fda.gov/medwatch